Business Description
Boston Therapeutics, Inc. is a pharmaceutical company focused on the development, manufacture and commercialization of novel compounds to address unmet medical needs in the areas of diabetes and inflammatory diseases.The Company's products are based on the platform of applied complex carbohydrate chemistry in pharmaceutical and over-the-counter products.
Details
| CEO: |
David Platt, Ph.D. |
| Issue Type: |
Common Stock |
| Auditors: |
McGladrey, LLP |
Industry Classifications
| Sector: |
Healthcare |
| Industry: |
Drugs |
| Sub-Industry: |
Pharmaceutical |
| NAICS: |
Pharmaceutical Preparation Manufacturing (325412) |
| SIC: |
Pharmaceutical Preparations (2834) |
|
Email Alerts
